Regenerative Medicine Market 2025 Growth Trends, Share - Global Analysis and Forecasts

Regenerative Medicine Market to 2025 - Global Analysis and Forecasts By Product (Cell Based and Acellular); Therapy (Gene Therapy, Cell Therapy, Tissue Engineering, and Other Therapies); and By Application (Oncology, Orthopedic & Musculoskeletal Disorders, Cardiology, Dermatology, and Other Applications)

Report Code: TIPHE100001194 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Regenerative medicine is an interdisciplinary field of medicine that is used for developing methods to grow, repair or replace diseased or damaged cells, tissues, and organs. Regenerative medicine involves the generation and use of therapeutic stem cells, tissue engineering and the production of artificial organs. Major focus in the regenerative medicine fields are cellular therapies, tissue engineering & biomaterials, and medical devices and artificial organs. Along with replacement of damaged organs, regenerative medicine also helps with the regeneration of the organs.

Increase in the global healthcare expenditure coupled with rising prevalence of genetic and chronic diseases is expected to fuel the market growth in the coming years. Considerable rise in the number of individuals opting for organ transplant is expected to provide substantial growth opportunity in the regenerative medicine market during the forecast period.

The "Global Regenerative Medicine Market Analysis to 2025" is a specialized and in-depth study of the regenerative medicine industry with a focus on the global market trend. The report aims to provide an overview of global regenerative medicine market with detailed market segmentation by, product, therapy and application. The global regenerative medicine market is expected to witness substantial growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

Based on product, the market is segmented as, cell based and acellular. The cell based segment is further categorized as, allogeneic and autologous. On the basis of therapy, the market is classified as, gene therapy, cell therapy, tissue engineering, and other therapies. The regenerative medicine market is segmented based on application such as, oncology, orthopedic & musculoskeletal disorders, cardiology, dermatology, and other applications.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global regenerative medicine market based on product, therapy and application. It also provides market size and forecast till 2025 for overall Regenerative Medicine market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East & Africa (MEA) and South and Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.
?
North America is expected to hold significant share in the regenerative medicine market, owing to favorable reimbursement and regulatory policies in the United States. The demand for regenerative medicine in Asia Pacific is anticipated to grow at a steady rate during the forecast period, due to increased healthcare expenditure in China and India.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The report also includes the profiles of key regenerative medicine manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last three years, key development in past three years. Some of the key players influencing the market are Stryker, Medtronic, Organogenesis Inc., Osiris Therapeutics, Inc., MiMedx, uniQure N.V., Vericel Corporation, COOK BIOTECH, INC., Integra LifeSciences Corporation, and NuVasive, Inc. among others.

1 Introduction
1.1 Scope of Study
1.2 The Insight Partners Research Report Guidance

2 Key Takeaways

3 Regenerative Medicine Market Landscape
3.1 Market Overview
3.2 Market Segmentation
3.2.1 Regenerative Medicine Market - By Product
3.2.2 Regenerative Medicine Market - By Therapy
3.2.3 Regenerative Medicine Market - By Application
3.2.4 Regenerative Medicine Market - By Region
3.2.4.1 By Country
3.3 PEST Analysis
3.3.1 North America - PEST Analysis
3.3.2 Europe - PEST Analysis
3.3.3 Asia Pacific - PEST Analysis
3.3.4 Middle East and Africa - PEST Analysis
3.3.5 South and Central America - PEST Analysis

4 Regenerative Medicine Market - Key Industry Dynamics
4.1 Key Market Drivers
4.2 Key Market Restraints
4.3 Key Market Opportunities
4.4 Future Trends
4.5 Impact Analysis

5 Regenerative Medicine Market - Global Analysis
5.1 Global Regenerative Medicine Market Overview
5.2 Global Regenerative Medicine Market Revenue Forecasts and Analysis (US$ Mn)
5.3 Market Positioning/Market Share
5.4 Performance of Key Players
5.5 Expert Opinions
5.6 Clinical Trails

6 Regenerative Medicine Market Revenue and Forecasts to 2025 - Product (US$ Mn)
6.1 Overview
6.2 Product Market Forecasts and Analysis
6.3 Cell Based Market
6.3.1 Overview
6.3.2 Cell Based Market Revenue Forecasts and Analysis (US$ Mn)
6.3.3 Allogeneic Market
6.3.3.1 Overview
6.3.3.2 Allogeneic Market Revenue Forecasts and Analysis (US$ Mn)
6.3.4 Autologous Market
6.3.4.1 Overview
6.3.4.2 Autologous Market Revenue Forecasts and Analysis (US$ Mn)
6.4 Acellular Market
6.4.1 Overview
6.4.2 Acellular Market Revenue Forecasts and Analysis (US$ Mn)

7 Regenerative Medicine Market Revenue and Forecasts to 2025 - Therapy (US$ Mn)
7.1 Overview
7.2 Therapy Market Forecasts and Analysis
7.3 Gene Therapy Market
7.3.1 Overview
7.3.2 Gene Therapy Market Revenue Forecasts and Analysis (US$ Mn)
7.4 Cell Therapy Market
7.4.1 Overview
7.4.2 Cell Therapy Market Revenue Forecasts and Analysis (US$ Mn)
7.5 Tissue Engineering Market
7.5.1 Overview
7.5.2 Tissue Engineering Market Revenue Forecasts and Analysis (US$ Mn)
7.6 Other Therapies Market
7.6.1 Overview
7.6.2 Other Therapies Market Revenue Forecasts and Analysis (US$ Mn)

8 Regenerative Medicine Market Revenue and Forecasts to 2025 - Application (US$ Mn)
8.1 Overview
8.2 Application Market Forecasts and Analysis
8.3 Oncology Market
8.3.1 Overview
8.3.2 Oncology Market Revenue Forecasts and Analysis (US$ Mn)
8.4 Orthopedic & Musculoskeletal Disorders Market
8.4.1 Overview
8.4.2 Orthopedic & Musculoskeletal Disorders Market Revenue Forecasts and Analysis (US$ Mn)
8.5 Cardiology Market
8.5.1 Overview
8.5.2 Cardiology Market Revenue Forecasts and Analysis (US$ Mn)
8.6 Dermatology Market
8.6.1 Overview
8.6.2 Dermatology Market Revenue Forecasts and Analysis (US$ Mn)
8.7 Other Applications Market
8.7.1 Overview
8.7.2 Other Applications Market Revenue Forecasts and Analysis (US$ Mn)

9 North America Regenerative Medicine Market Revenue and Forecasts to 2025 - Country Analysis
9.1 North America Regenerative Medicine Market Overview
9.2 North America Regenerative Medicine Market Revenue Forecasts and Analysis (US$ Mn)
9.3 North America Market Forecasts and Analysis - By Product (US$ Mn)
9.3.1 North America Cell Based Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.4 North America Market Forecasts and Analysis - By Therapy (US$ Mn)
9.5 North America Market Forecasts and Analysis - By Application (US$ Mn)
9.6 North America Market Forecasts and Analysis - By Country (US$ Mn)
9.7 US Market Overview
9.7.1 US Regenerative Medicine Market Revenue Forecasts and Analysis-By Product (US$ Mn)
9.7.1.1 US Cell Based Market Product Revenue Forecasts and Analysis - By Type (US$ Mn)
9.7.2 US Regenerative Medicine Market Revenue Forecasts and Analysis-By Therapy (US$ Mn)
9.7.3 US Regenerative Medicine Market Revenue Forecasts and Analysis-By Application (US$ Mn)
9.8 Canada Market Overview
9.8.1 Canada Regenerative Medicine Market Revenue Forecasts and Analysis-By Product (US$ Mn)
9.8.1.1 Canada Cell Based Market Product Revenue Forecasts and Analysis - By Type (US$ Mn)
9.8.2 Canada Regenerative Medicine Market Revenue Forecasts and Analysis-By Therapy (US$ Mn)
9.8.3 Canada Regenerative Medicine Market Revenue Forecasts and Analysis-By Application (US$ Mn)
9.9 Mexico Market Overview
9.9.1 Mexico Regenerative Medicine Market Revenue Forecasts and Analysis-By Product (US$ Mn)
9.9.1.1 Mexico Cell Based Market Product Revenue Forecasts and Analysis - By Type (US$ Mn)
9.9.2 Mexico Regenerative Medicine Market Revenue Forecasts and Analysis-By Product (US$ Mn)
9.9.3 Mexico Regenerative Medicine Market Revenue Forecasts and Analysis-By Application (US$ Mn)

10 Europe Regenerative Medicine Market Revenue and Forecasts to 2025 - Country Analysis
10.1 Europe Regenerative Medicine Market Overview
10.2 Europe Regenerative Medicine Market Revenue Forecasts and Analysis (US$ Mn)
10.3 Europe Market Forecasts and Analysis - By Product (US$ Mn)
10.3.1 Europe Cell Based Market Product Revenue Forecasts and Analysis - By Type (US$ Mn)
10.4 Europe Market Forecasts and Analysis - By Therapy (US$ Mn)
10.5 Europe Market Forecasts and Analysis - By Application (US$ Mn)
10.6 Europe Market Forecasts and Analysis - By Country (US$ Mn)
10.7 UK Market Overview
10.7.1 UK Regenerative Medicine Market Revenue Forecasts and Analysis-By Product (US$ Mn)
10.7.1.1 UK Cell Based Market Product Revenue Forecasts and Analysis - By Type (US$ Mn)
10.7.2 UK Regenerative Medicine Market Revenue Forecasts and Analysis-By Therapy (US$ Mn)
10.7.3 UK Regenerative Medicine Market Revenue Forecasts and Analysis-By Application (US$ Mn)
10.8 Germany Market Overview
10.8.1 Germany Regenerative Medicine Market Revenue Forecasts and Analysis-By Product (US$ Mn)
10.8.1.1 Germany Cell Based Market Product Revenue Forecasts and Analysis - By Type (US$ Mn)
10.8.2 Germany Regenerative Medicine Market Revenue Forecasts and Analysis-By Therapy (US$ Mn)
10.8.3 Germany Regenerative Medicine Market Revenue Forecasts and Analysis-By Application (US$ Mn)
10.9 France Market Overview
10.9.1 France Regenerative Medicine Market Revenue Forecasts and Analysis-By Product (US$ Mn)
10.9.1.1 France Cell Based Market Product Revenue Forecasts and Analysis - By Type (US$ Mn)
10.9.2 France Regenerative Medicine Market Revenue Forecasts and Analysis-By Therapy (US$ Mn)
10.9.3 France Regenerative Medicine Market Revenue Forecasts and Analysis-By Application (US$ Mn)
?
11 Asia Pacific Regenerative Medicine Market Revenue and Forecasts to 2025 - Country Analysis
11.1 Asia Pacific Regenerative Medicine Market Overview
11.2 Asia Pacific Regenerative Medicine Market Revenue Forecasts and Analysis (US$ Mn)
11.3 Asia Pacific Market Forecasts and Analysis - By Product (US$ Mn)
11.3.1 Asia Pacific Cell Based Market Product Revenue Forecasts and Analysis - By Type (US$ Mn)
11.4 Asia Pacific Market Forecasts and Analysis - By Therapy (US$ Mn)
11.5 Asia Pacific Market Forecasts and Analysis - By Application (US$ Mn)
11.6 Asia Pacific Market Forecasts and Analysis - By Country (US$ Mn)
11.7 Japan Market Overview
11.7.1 Japan Regenerative Medicine Market Revenue Forecasts and Analysis-By Product (US$ Mn)
11.7.1.1 Japan Cell Based Market Product Revenue Forecasts and Analysis - By Type (US$ Mn)
11.7.2 Japan Regenerative Medicine Market Revenue Forecasts and Analysis-By Therapy (US$ Mn)
11.7.3 Japan Regenerative Medicine Market Revenue Forecasts and Analysis-By Application (US$ Mn)
11.8 China Market Overview
11.8.1 China Regenerative Medicine Market Revenue Forecasts and Analysis-By Product (US$ Mn)
11.8.1.1 China Cell Based Market Product Revenue Forecasts and Analysis - By Type (US$ Mn)
11.8.2 China Regenerative Medicine Market Revenue Forecasts and Analysis-By Therapy (US$ Mn)
11.8.3 China Regenerative Medicine Market Revenue Forecasts and Analysis-By Application (US$ Mn)
?
11.9 India Market Overview
11.9.1 India Regenerative Medicine Market Revenue Forecasts and Analysis-By Product (US$ Mn)
11.9.1.1 India Cell Based Market Product Revenue Forecasts and Analysis - By Type (US$ Mn)
11.9.2 India Regenerative Medicine Market Revenue Forecasts and Analysis-By Therapy (US$ Mn)
11.9.3 India Regenerative Medicine Market Revenue Forecasts and Analysis-By Application (US$ Mn)

12 Middle East and Africa (MEA) Regenerative Medicine Market Revenue and Forecasts to 2025 - Geographical Analysis
12.1 Middle East & Africa Regenerative Medicine Market Overview
12.2 Middle East & Africa Regenerative Medicine Market Revenue Forecasts and Analysis (US$ Mn)
12.3 Middle East & Africa Market Forecasts and Analysis - By Product (US$ Mn)
12.3.1 Middle East & Africa Cell Based Market Product Revenue Forecasts and Analysis - By Type (US$ Mn)
12.4 Middle East & Africa Market Forecasts and Analysis - By Therapy (US$ Mn)
12.5 Middle East & Africa Market Forecasts and Analysis - By Application (US$ Mn)
12.6 Middle East & Africa Market Forecasts and Analysis - By Country (US$ Mn)
12.7 South Africa Market Overview
12.7.1 South Africa Regenerative Medicine Market Revenue Forecasts and Analysis-By Product (US$ Mn)
12.7.1.1 South Africa Cell Based Market Product Revenue Forecasts and Analysis - By Type (US$ Mn)
12.7.2 South Africa Regenerative Medicine Market Revenue Forecasts and Analysis-By Therapy (US$ Mn)
12.7.3 South Africa Regenerative Medicine Market Revenue Forecasts and Analysis-By Application (US$ Mn)
?
12.8 Saudi Arabia Market Overview
12.8.1 Saudi Arabia Regenerative Medicine Market Revenue Forecasts and Analysis-By Product (US$ Mn)
12.8.1.1 Saudi Arabia Cell Based Market Product Revenue Forecasts and Analysis - By Type (US$ Mn)
12.8.2 Saudi Arabia Regenerative Medicine Market Revenue Forecasts and Analysis-By Therapy (US$ Mn)
12.8.3 Saudi Arabia Regenerative Medicine Market Revenue Forecasts and Analysis-By Application (US$ Mn)
12.9 UAE Market Overview
12.9.1 UAE Regenerative Medicine Market Revenue Forecasts and Analysis-By Product (US$ Mn)
12.9.1.1 UAE Cell Based Market Product Revenue Forecasts and Analysis - By Type (US$ Mn)
12.9.2 UAE Regenerative Medicine Market Revenue Forecasts and Analysis-By Therapy (US$ Mn)
12.9.3 UAE Regenerative Medicine Market Revenue Forecasts and Analysis-By Application (US$ Mn)

13 South and Central America Regenerative Medicine Market Revenue and Forecasts to 2025 - Geographical Analysis
13.1 South and Central America Regenerative Medicine Market Overview
13.2 South and Central America Regenerative Medicine Market Revenue Forecasts and Analysis (US$ Mn)
13.3 South and Central America Market Forecasts and Analysis - By Product (US$ Mn)
13.3.1 South and Central America Cell Based Market Product Revenue Forecasts and Analysis - By Type (US$ Mn)
13.4 South and Central America Market Forecasts and Analysis - By Therapy (US$ Mn)
13.5 South and Central America Market Forecasts and Analysis - By Application (US$ Mn)
13.6 South and Central America Market Forecasts and Analysis - By Country (US$ Mn)
?
13.7 Brazil Market Overview
13.7.1 Brazil Regenerative Medicine Market Revenue Forecasts and Analysis-By Product (US$ Mn)
13.7.1.1 Brazil Cell Based Market Product Revenue Forecasts and Analysis - By Type (US$ Mn)
13.7.2 Brazil Regenerative Medicine Market Revenue Forecasts and Analysis-By Therapy (US$ Mn)
13.7.3 Brazil Regenerative Medicine Market Revenue Forecasts and Analysis-By Application (US$ Mn)

14 Industry Landscape
14.1 Organic Growth Strategies
14.1.1 New Product Launches
14.1.2 Marketing & Promotional Activities
14.2 Inorganic Growth Strategies
14.2.1 Partnerships, Collaborations, and Joint Ventures
14.2.2 Mergers & Acquisitions

15 Regenerative Medicine Market, Key Company Profiles
15.1 Stryker
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Financial Overview
15.1.4 Product Portfolio
15.1.5 Product Pipeline
15.1.6 SWOT Analysis
15.1.7 Key Developments
15.2 Medtronic
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Financial Overview
15.2.4 Product Portfolio
15.2.5 Product Pipeline
15.2.6 SWOT Analysis
15.2.7 Key Developments
15.3 Organogenesis Inc.
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Financial Overview
15.3.4 Product Portfolio
15.3.5 Product Pipeline
15.3.6 SWOT Analysis
15.3.7 Key Developments
15.4 Osiris Therapeutics, Inc.
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Financial Overview
15.4.4 Product Portfolio
15.4.5 Product Pipeline
15.4.6 SWOT Analysis
15.4.7 Key Developments
15.5 MiMedx
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Financial Overview
15.5.4 Product Portfolio
15.5.5 Product Pipeline
15.5.6 SWOT Analysis
15.5.7 Key Developments
15.6 uniQure N.V.
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Financial Overview
15.6.4 Product Portfolio
15.6.5 Product Pipeline
15.6.6 SWOT Analysis
15.6.7 Key Developments

15.7 Vericel Corporation
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Financial Overview
15.7.4 Product Portfolio
15.7.5 Product Pipeline
15.7.6 SWOT Analysis
15.7.7 Key Developments
15.8 COOK BIOTECH, INC.
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Financial Overview
15.8.4 Product Portfolio
15.8.5 Product Pipeline
15.8.6 SWOT Analysis
15.8.7 Key Developments
15.9 Integra LifeSciences Corporation
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Financial Overview
15.9.4 Product Portfolio
15.9.5 Product Pipeline
15.9.6 SWOT Analysis
15.9.7 Key Developments
15.10 NuVasive, Inc.
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Financial Overview
15.10.4 Product Portfolio
15.10.5 Product Pipeline
15.10.6 SWOT Analysis
15.10.7 Key Developments
?
16 Appendix
16.1 About The Insight Partners
16.2 Glossary of Terms
16.3 Research Methodology

The List of Companies

1. Stryker
2. Medtronic
3. Organogenesis Inc.
4. Osiris Therapeutics, Inc.
5. MiMedx
6. uniQure N.V.
7. Vericel Corporation
8. COOK BIOTECH, INC.
9. Integra LifeSciences Corporation
10. NuVasive, Inc.

Select License Type
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book